IRIS
DE LUCA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.205
AS - Asia 3.003
NA - Nord America 2.706
SA - Sud America 1.008
AF - Africa 90
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.562
RU - Federazione Russa 2.264
SG - Singapore 1.291
BR - Brasile 836
CN - Cina 560
HK - Hong Kong 516
IT - Italia 407
BD - Bangladesh 157
VN - Vietnam 149
FR - Francia 118
DE - Germania 93
IN - India 75
IE - Irlanda 65
GB - Regno Unito 57
AR - Argentina 56
CA - Canada 56
MX - Messico 56
AT - Austria 37
NL - Olanda 37
ZA - Sudafrica 35
IQ - Iraq 33
EC - Ecuador 30
TR - Turchia 30
CO - Colombia 24
PK - Pakistan 24
FI - Finlandia 23
SE - Svezia 19
ID - Indonesia 18
UZ - Uzbekistan 18
CL - Cile 17
SA - Arabia Saudita 17
UA - Ucraina 17
VE - Venezuela 16
JP - Giappone 15
PL - Polonia 15
ES - Italia 14
MY - Malesia 14
PH - Filippine 13
MA - Marocco 12
PE - Perù 12
JO - Giordania 10
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
IL - Israele 8
JM - Giamaica 8
PY - Paraguay 8
KE - Kenya 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
LB - Libano 5
LT - Lituania 5
SV - El Salvador 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
HN - Honduras 4
NP - Nepal 4
PT - Portogallo 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KG - Kirghizistan 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
Totale 10.005
Salva come PNG Salva come JPEG
Città #
Ashburn 747
Moscow 736
Singapore 532
Hong Kong 513
San Jose 374
Dallas 320
Beijing 112
The Dalles 108
Los Angeles 106
Council Bluffs 85
Lauterbourg 81
Dublin 64
New York 61
Messina 56
Ho Chi Minh City 53
Buffalo 52
São Paulo 52
Santa Clara 43
Catania 39
Redondo Beach 39
Hanoi 38
Frankfurt am Main 33
Rio de Janeiro 33
Mexico City 30
Paternò 30
Belo Horizonte 27
Orem 27
Hyderabad 26
Munich 26
Guangzhou 25
Amsterdam 23
Tianjin 23
Vienna 23
Boardman 22
Johannesburg 21
Shanghai 19
Turin 19
Brooklyn 16
Dhaka 16
Montreal 16
Nuremberg 16
Porto Alegre 16
Chicago 15
Tashkent 15
Chennai 14
Manchester 14
Tokyo 14
Milan 13
Guayaquil 12
Phoenix 12
San Francisco 12
Toronto 12
Warsaw 12
Caxias do Sul 11
Chandler 11
Curitiba 11
Shenzhen 11
Kuala Lumpur 10
London 10
Quito 10
Ribeirão Preto 10
Rome 10
Amman 9
Atlanta 9
Baghdad 9
Charlotte 9
Denver 9
Haiphong 9
Helsinki 9
Houston 9
Medellín 9
Seattle 9
Abidjan 8
Ankara 8
Baku 8
Boston 8
Campinas 8
Prineville 8
Chongqing 7
City of London 7
Franca 7
Goiânia 7
Istanbul 7
Lappeenranta 7
Lima 7
New Delhi 7
Riyadh 7
Santo André 7
Stockholm 7
Washington 7
Biên Hòa 6
Caracas 6
Florianópolis 6
Guarulhos 6
Jaipur 6
Jeddah 6
Kingston 6
Lahore 6
Maceió 6
Nairobi 6
Totale 5.219
Salva come PNG Salva come JPEG
Nome #
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 199
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 175
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 151
Immature platelet fraction and the extent of coronary artery disease: a single centre study 150
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 144
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 122
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 111
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 110
A meta-analytic overview of thrombectomy during primary angioplasty 104
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 101
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 98
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 92
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 88
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 87
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 87
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 84
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 84
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 84
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 83
Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention 83
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 83
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 83
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 82
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 81
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 81
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 81
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 80
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 80
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 79
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 78
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 78
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 78
Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention 78
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 78
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 78
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 77
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 77
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 77
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 77
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 76
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 76
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 76
An unusual case of ECG ST-segment elevation 75
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 75
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 75
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 75
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 75
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 74
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 74
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 74
Immature platelet fraction and the extent of coronary artery disease: A single centre study 74
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 74
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 73
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 73
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 73
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 72
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry 72
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 72
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 72
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 72
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 71
Adjunctive antithrombotic therapy during Primary PCI 71
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 71
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 71
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 71
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease' 71
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 71
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 71
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 70
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 70
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 69
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 69
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 69
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial 69
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 68
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 68
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers 67
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 67
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 66
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 66
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 66
Switching from clopidogrel to prasugrel in patients having coronary stent implantation 65
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 64
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 64
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials 64
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 63
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 63
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 63
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 62
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 62
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 62
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 61
Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI 60
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 59
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 59
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 59
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale 58
Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography 58
Single versus Dual-Operator Approaches for Percutaneous Coronary Interventions within Chronic Total Occlusion—An Analysis of 27,788 Patients 57
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials 57
Totale 7.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023708 2 3 1 4 4 5 3 4 11 473 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/20252.566 21 27 28 176 142 106 90 338 621 152 321 544
2025/20266.921 310 478 454 327 493 1.269 977 770 786 416 370 271
Totale 10.612